Oncobiologics IPO: We Suggest Holding Off
May 04, 2016 at 12:20 PM EDT
ONS expects to price its Nasdaq offering this Thurs., 5.5; lead underwriters are Barclays and Jeffries. Oncobiologics Incorporated (Nasdaq: ONS) expects to raise $53 million.
